NEW YORK--(BUSINESS WIRE)--July 11, 2006--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or “The Company”) (NASDAQ: OMRI - News), a commercial-stage biopharmaceutical company that develops and markets biosurgical and passive immunotherapy products, announced today that Michael Burshtine, Senior Vice President and Chief Financial Officer, is scheduled to give a company presentation at the C.E. Unterberg, Towbin Emerging Growth Conference on Wednesday, July 12, 2006 at 1:44 p.m. EDT at the Mandarin Oriental Hotel in New York City.
